Femoral Access and Femoral Vascular Closure

Femoral Access and Femoral Vascular Closure

On-Demand Webcast
Faculty

Zoltan G. Turi, MD, MSCAI, FACC
Professor of Medicine
Associate Director, Division of Cardiovascular
Disease and Hypertension
Rutgers Robert Wood Johnson Medical School
Director, Structural Heart Program
Robert Wood Johnson University Hospital
New Brunswick, New Jersey

PROVIDER STATEMENT

 In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

INTENDED LEARNERS

This activity is designed for interventional cardiologists, vascular surgeons, interventional radiologists, nurses, technologists, and other cardiology related healthcare professionals.

LEARNING OBJECTIVES

After completing this activity, participants should be able to:

  • Review various techniques for obtaining common femoral arterial access, highlighting modern evidence based techniques
  • Develop strategies for sheath management 
  • Discuss methods to minimize complications
  • Provide overview of available closure techniques
  • Review data from meta-analyses of randomized trials comparing femoral vascular closure devices to manual compression including bleeding complications and time to ambulation
  • Review best practices to optimize outcomes for vascular access and closure
CLAIMING CREDIT

This on-demand webcast is available with synchronized slides and video.

To be eligible for credit, participants must complete the online activity, a post-test assessment, and the evaluation by January 31, 2021. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.

There is no fee associated with this activity.

Release date: December 19, 2014
Expiration date: January 31, 2021
Date of last review: January 31, 2020

Estimated time to complete: 1 hour

There is no fee associated with this activity.

COMMERCIAL SUPPORT

NACCME would like to thank the following company who has supported the "Femoral Access and Femoral Vascular Closure" through educational grants and/or in-kind support: Cardinal Health

CONTINUING EDUCATION

 In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS

NACCME designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING

This continuing nursing education activity awards 1.0 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.

PHYSICIAN ASSISTANTS

NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 credit(s). PAs should only claim credit commensurate with the extent of their participation.

VASCULAR & INTERVENTIONAL RADIOGRAPHERS

Femoral Access and Femoral Vascular Closure taking place on January 31, 2020 to January 31, 2021 has been approved for 1.0 A+ ARRT CE credits by the Association for Vascular and Interventional Radiographers (AVIR). The AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).

USE OF PROPRIETARY NAMES

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.

Financial Disclosure and Conflicts of Interest

NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

Clinical Reviewers

Alan Dardik, MD PhD
Professor of Surgery (Vascular) and of Cellular and Molecular Physiology;
Vice Chair (Faculty Affairs), Surgery
Yale School of Medicine
New Haven, CT

Nurse Planner: Susie Seaman, NP, MSN, CWOCN, Infectious Disease Consultants/San Diego Infusion Center, San Diego, CA

Planning Committee

In addition to the faculty listed below, NACCME planners and staff include Chris Bolwell, Samantha Conforti, Randy Robbin, Margie Stefan and Colleen Waters

Chris Bolwell is a shareholder of GlaxoSmithKline. GlaxoSmithKline is not supporting this activity, nor does any content relate to their product/service.

Faculty

The faculty have reported the following:

Ms. Seaman: Speakers' Bureau—Next Science

Dr. Dardik and Dr. Turi have disclosed no relevant financial relationships with any commercial interest.

ADA STATEMENT

North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

PRIVACY POLICY

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2020 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.